DOROTA RYTWINSKI: Open Payments
NPI 1003960428 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,491 in 149 payments from 19 companies in 2025. Trend: 2023 $2,021 · 2024 $2,316 · 2025 $2,491
Food & beverage: $2,372Education: $119
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 9 | $246 |
| Teva Pharmaceuticals USA, Inc. | 12 | $239 |
| ABBVIE INC. | 16 | $232 |
| E.R. Squibb & Sons, L.L.C. | 7 | $211 |
| Neurocrine BioSciences, Inc. | 12 | $207 |
| Alkermes, Inc. | 15 | $195 |
| Vanda Pharmaceuticals Inc. | 7 | $191 |
| Lundbeck LLC | 17 | $176 |
| Otsuka America Pharmaceutical, Inc. | 17 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $150 |
Products named: REXULTI, Qelbree, VRAYLAR, COBENFY, INGREZZA, FANAPT, ARISTADA, CAPLYTA.
Industry payments across OH — which companies pay providers there.
